started · updated
Establishment Labs Q2 2026 Earnings Miss and Analyst Price Target Rises
On August 6, 2026, Establishment Labs Holdings Inc. reported second‑quarter 2026 results with revenue of $67.54 million, slightly above the consensus estimate of $65.79 million. The company posted earnings per share of –$0.39, missing the consensus forecast of –$0.34 by $0.05. Shares fell to $79.05 during the trading day, down $12.20.
Analyst coverage turned more optimistic: Needham & Company raised its price target to $95 (from $86), Mizuho increased its target to $105 (from $100), TD Cowen lifted its target to $117 (from $95), and Citigroup moved its target to $92 (from $76). The consensus price target among analysts is $96.50. Ratings include Buy from Needham, Mizuho, TD Cowen and BTIG, Hold from Citigroup, and Sell from Weiss Ratings.
The earnings call featured CEO Filippo Caldini, CFO Cassandra Harris and VP Malavika William, who reminded listeners that forward‑looking statements are subject to risks and uncertainties.
Entities
Cassandra Harris · Establishment Labs Holdings Inc. · Filippo Caldini · Needham & Company LLC
Claims
What the coverage asserts, and how many sources carry each claim.
- [○ 1 SOURCE] Mizuho increased its price target for Establishment Labs to $105 from $100.
- [○ 1 SOURCE] Needham & Company raised its price target for Establishment Labs to $95 from $86.
- [○ 1 SOURCE] TD Cowen raised its price target for Establishment Labs to $117 from $95.
- [○ 1 SOURCE] Establishment Labs reported Q2 2026 revenue of $67.54 million.
- [○ 1 SOURCE] The consensus price target among analysts for Establishment Labs is $96.50.
- [○ 1 SOURCE] Establishment Labs reported earnings per share of –$0.39 for Q2 2026.
- [○ 1 SOURCE] Consensus revenue estimate for Q2 2026 was $65.79 million.
- [○ 1 SOURCE] Consensus EPS estimate for Q2 2026 was –$0.34.